Loading...

Analyst Commentary Highlights Mixed Views as Reckitt Benckiser Updates Guidance and Maintains Valuation

Published
09 Mar 25
Updated
05 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
23.0%
7D
0.8%

Author's Valuation

UK£62.56.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 05 Nov 25

Fair value Increased 3.60%

RKT: Future Performance Will Reflect Balanced Outlook Amid Adjusted Earnings Expectations

Analysts have raised their price target for Reckitt Benckiser Group from £55.55 to £56.47, citing slight revisions to revenue growth and profit margin expectations, as well as updated fair value estimates. Analyst Commentary Recent street research shows a mixed but generally constructive outlook from analysts regarding Reckitt Benckiser Group.

Shared on 22 Oct 25

Analyst Commentary Highlights Mixed Views as Reckitt Benckiser Updates Guidance and Maintains Valuation

Reckitt Benckiser Group’s consensus analyst price target was revised downward to 5,555 GBp from 5,920 GBp. This change reflects analysts’ caution amid mixed signals about growth prospects and market positioning. Analyst Commentary Recent analyst activity surrounding Reckitt Benckiser Group provides a balanced perspective, with both upward and downward revisions to price targets.

Shared on 08 Oct 25

Fair value Increased 0.98%

India And China Health And Hygiene Trends Will Spark Opportunity

Analysts have modestly increased their price target for Reckitt Benckiser Group, raising fair value by approximately £0.59 to £60.33. This change is due to slightly improved revenue growth expectations and continued sector stability.

Shared on 01 May 25

Fair value Increased 2.77%

India And China Health And Hygiene Trends Will Spark Opportunity

Shared on 23 Apr 25

Fair value Decreased 0.24%

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 0.24%

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 6.01%

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 6.36%

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Decreased 0.47%

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects

AnalystConsensusTarget has increased revenue growth from 2.4% to 3.0% and increased shares outstanding growth rate from -0.0% to 0.0%.

Shared on 12 Mar 25

Fair value Increased 3.73%

Focus On Emerging Markets And High-Margin Categories Will Strengthen Future Prospects